Cervical Priming by Vaginal or Oral Misoprostol Before Operative Hysteroscopy: A Double-Blind, Randomized Controlled...

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Reproductive Medicine

Background:

• Cervical ripening is crucial for gynecological procedures.
• Misoprostol is commonly used for cervical priming.
• Comparing oral versus vaginal administration of misoprostol is important for optimizing patient care.

Purpose of the Study:

• To evaluate the efficacy of oral misoprostol compared to vaginal misoprostol for cervical ripening.
• To assess differences in cervical canal width, ease of dilatation, and adverse effects between oral and vaginal misoprostol administration.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted.
• 390 patients undergoing operative hysteroscopy were enrolled.
• Patients received either oral misoprostol, vaginal misoprostol, or placebo 12 hours before the procedure.

Main Results:

• Both oral and vaginal misoprostol significantly increased endocervical canal width and eased cervical dilatation compared to placebo (p < .001).
• No significant difference was found in canal width, ease of dilatation, or time to dilatation between oral and vaginal misoprostol groups (p > .05).
• Adverse effects were comparable across all groups.

Conclusions:

• Oral misoprostol is a viable and effective alternative to vaginal misoprostol for cervical priming.
• The route of administration does not significantly impact the efficacy or safety of misoprostol for cervical ripening.